News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health Perspectives
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pain
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
ASH 2025|
Spain has healthcare lessons for the U.S.|
DTC drug sales|
2025 Fall Clinical Dermatology|
AMCP Nexus 2025|
ASRS 2025
Advertisement

Mary A. Inman

Advertisement

Articles by Mary A. Inman

The risks and rewards of medical loss ratio come to managed care

ByTim McCormack,Mary A. Inman,Jessica T. Moore
March 12th 2015

Executives of Medicare managed plans can benefit from knowing the challenges of the Medical Loss Ratio, a key cost control tool that went into effect last year.

Advertisement

Latest Updated Articles

  • The risks and rewards of medical loss ratio come to managed care
    The risks and rewards of medical loss ratio come to managed care

    Published: March 12th 2015 | Updated:



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

Positive results for Casgevy but with one patient death from myeloablative busulfan conditioning | ASH 2025

2

IV iron treatment improves survival, increases hemoglobin levels in anemic patients with acute bacterial infection | ASH 2025

3

Quadruplet treatments for multiple myeloma are rising but access varies | ASH 2025

4

AstraZeneca’s Imfinzi gains landmark FDA approval for early gastric and gastroesophageal cancers

5

Gene therapy in the real world: High priced, a long process and still relatively few patients | ASH 2025

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us